FibroBiologics【FBLG】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.75

買値

1.50

売値

1.83

出来高

167,627

1.72 日の範囲 2.00

1.0779 52 週間の範囲 55.00

時価総額

60.653M

前日終値

1.91

始値

1.95

時刻

1.84

最終取引時間

財務取引量

US$ 305,581

VWAP

1.823

平均取引量 (3 か月)

157,547

発行済株式数

34,659,125

配当利回り

PER

-3.18

1 株当たり利益 (EPS)

-0.55

歳入

純利益

-19.06M

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.fibrobiologics.com

本社

Wilmington, Delaware, USA

設立

FibroBiologics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker FBLG. The last closing price for FibroBiologics was US$1.91. Over the last year, FibroBiologics shares have traded in a share price range of US$ 1.0779 to US$ 55.00.

FibroBiologics currently has 34,659,125 shares in issue. The market capitalisation of FibroBiologics is US$66.20 million. FibroBiologics has a price to earnings ratio (PE ratio) of -3.18.

Form POS AM - Post-Effective amendments for registration statement

Form EFFECT - Notice of Effectiveness

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...

Form 4 - Statement of changes in beneficial ownership of securities

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...

Form S-1 - General form for registration of securities under the Securities Act of 1933

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.3	-14.6341463415	2.05	2.15	1.747	135382	1.92802515	CS
4	-0.28	-13.7931034483	2.03	2.51	1.747	146658	2.10824554	CS
12	-1.13	-39.2361111111	2.88	3.89	1.747	157547	2.60640319	CS
26	-3.55	-66.9811320755	5.3	5.62	1.0779	290384	2.94795614	CS
52	-28.25	-94.1666666667	30	55	1.0779	222074	4.94921072	CS
156	-28.25	-94.1666666667	30	55	1.0779	222074	4.94921072	CS
260	-28.25	-94.1666666667	30	55	1.0779	222074	4.94921072	CS

FBLG - Frequently Asked Questions (FAQ)

What is the current FibroBiologics share price?

The current share price of FibroBiologics is US$ 1.75

How many FibroBiologics shares are in issue?

FibroBiologics has 34,659,125 shares in issue

What is the market cap of FibroBiologics?

The market capitalisation of FibroBiologics is USD 66.2M

What is the 1 year trading range for FibroBiologics share price?

FibroBiologics has traded in the range of US$ 1.0779 to US$ 55.00 during the past year

What is the PE ratio of FibroBiologics?

The price to earnings ratio of FibroBiologics is -3.18

What is the reporting currency for FibroBiologics?

FibroBiologics reports financial results in USD

What is the latest annual profit for FibroBiologics?

The latest annual profit of FibroBiologics is USD -19.06M

What is the registered address of FibroBiologics?

The registered address for FibroBiologics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the FibroBiologics website address?

The website address for FibroBiologics is www.fibrobiologics.com

Which industry sector does FibroBiologics operate in?

FibroBiologics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BTCTBTC Digital Ltd	US$ 8.2697 (73.73%)	61.45M
BDMDBaird Medical Investment Holdings Ltd	US$ 8.80 (62.36%)	18.63M
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
NUKKNukkleus Inc	US$ 29.97 (45.98%)	19.09M
GSITGSI Technology	US$ 3.97 (44.36%)	87.7M
DOGZDogness International Corporation	US$ 18.23 (-58.77%)	740.45k
ORKTOrangeKloud Technology Inc	US$ 3.02 (-24.88%)	21.08M
PMAXPowell Max Ltd	US$ 0.6364 (-23.31%)	4.17M
LGCBLinkage Global Inc	US$ 0.2876 (-22.27%)	890.66k
YYAIConnexa Sports Technologies Inc	US$ 0.8299 (-20.20%)	602.48k
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
GCTKGlucoTrack Inc	US$ 0.0852 (15.45%)	465.22M
RIMEAlgorhythm Holdings Inc	US$ 0.0406 (-4.02%)	387.23M
TGLTreasure Global Inc	US$ 0.2459 (14.75%)	267.1M
NVDANVIDIA Corporation	US$ 137.71 (3.10%)	201.4M